SpeeDx Pty, Ltd. has announced a distribution agreement with Diagen, a leading Scandinavian clinical laboratory supplier specialising in diagnostic products. This agreement will open important sales channels in Sweden, Norway and Denmark for SpeeDx’s PlexPCR® and unique, multiplexed ResistancePlus® real-time polymerase chain reaction product lines.
“Scandinavia is home to some important thought leaders influencing sexual health and STI testing practices across Europe,” said Colin Denver, CEO of SpeeDx. “We see our partnership with Diagen as key to offering the best service to laboratories across these important markets.”
Read the full press release here